Carmichael Hill & Associates’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$67.6K Buy
195
+11
+6% +$3.79K 0.02% 320
2024
Q2
$60.8K Buy
184
+9
+5% +$3.1K 0.02% 313
2024
Q1
$63.6K Hold
175
0.03% 312
2023
Q4
$52.4K Sell
175
-9
-5% -$2.63K 0.02% 334
2023
Q3
$52.6K Hold
184
0.02% 323
2023
Q2
$51.6K Sell
184
-69
-27% -$18K 0.02% 328
2023
Q1
$64.7K Hold
253
0.03% 280
2022
Q4
$83.8K Sell
253
-7
-3% -$2.21K 0.04% 258
2022
Q3
$72K Hold
260
0.04% 267
2022
Q2
$69K Buy
260
+9
+4% +$2.32K 0.04% 286
2022
Q1
$60K Hold
251
0.03% 320
2021
Q4
$58K Hold
251
0.03% 341
2021
Q3
$50K Hold
251
0.02% 345
2021
Q2
$60K Sell
251
-9
-3% -$2.25K 0.03% 315
2021
Q1
$63K Hold
260
0.03% 297
2020
Q4
$54K Buy
260
+14
+6% +$2.75K 0.03% 301
2020
Q3
$42K Hold
246
0.03% 315
2020
Q2
$46K Hold
246
0.03% 286
2020
Q1
$44K Hold
246
0.04% 273
2019
Q4
$50K Buy
+246
New +$45.1K 0.04% 282

Other funds holding CI

Carmichael Hill & Associates's CI Position: Q3 2024 in Review

Carmichael Hill & Associates increased its Cigna (CI) stake by 6% in Q3 2024, buying an estimated $3.79K and bringing the position to 195 shares worth $67.6K. The position accounts for 0.02% of the portfolio, ranked #320.

Carmichael Hill & Associates first reported a position in CI in Q4 2019 and has held it in 20 quarters since. The position peaked at $83.8K in Q4 2022. 1,703 funds tracked by Wall St. Rank hold CI as of Q3 2024.

  • Carmichael Hill & Associates held 195 shares of Cigna worth $67.6K as of Q3 2024.
  • Carmichael Hill & Associates bought 11 Cigna shares in Q3 2024, an estimated $3.79K.
  • Cigna made up 0.02% of Carmichael Hill & Associates's portfolio in Q3 2024, its #320 holding.
  • Carmichael Hill & Associates first reported a position in Cigna in Q4 2019 and has held it in 20 quarters since.
  • Carmichael Hill & Associates's Cigna position peaked at $83.8K in Q4 2022.
  • 1,703 funds tracked by Wall St. Rank held Cigna as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.